HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Ikejima Selected Research

mansonone E

7/2004Cytotoxic effects of mansonone E and F isolated from Ulmus pumila.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Ikejima Research Topics

Disease

30Melanoma (Melanoma, Malignant)
01/2017 - 04/2002
27Neoplasms (Cancer)
01/2022 - 01/2003
24Fibrosarcoma
09/2017 - 03/2004
15Breast Neoplasms (Breast Cancer)
01/2020 - 05/2007
10Inflammation (Inflammations)
01/2020 - 04/2010
9Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2007 - 01/2003
8Mitochondrial Diseases (Mitochondrial Disease)
09/2021 - 12/2006
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2013 - 01/2007
8Carcinoma (Carcinomatosis)
09/2012 - 12/2007
7Lymphoma (Lymphomas)
01/2020 - 03/2005
7Necrosis
09/2008 - 09/2003
5Liver Diseases (Liver Disease)
08/2022 - 09/2006
4Lung Neoplasms (Lung Cancer)
10/2017 - 01/2012
3Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy)
04/2022 - 01/2019
3Parkinson Disease (Parkinson's Disease)
11/2021 - 09/2021
3Neuroinflammatory Diseases
11/2021 - 04/2017
3Cognitive Dysfunction
09/2021 - 03/2010
3Fibrosis (Cirrhosis)
01/2020 - 07/2018
3Type 2 Diabetes Mellitus (MODY)
01/2020 - 06/2018
3Adenocarcinoma
01/2007 - 03/2004
2Bites and Stings (Sting)
11/2021 - 01/2021
2Diabetes Mellitus
08/2018 - 01/2012
2Alzheimer Disease (Alzheimer's Disease)
04/2018 - 01/2012
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2018 - 01/2018
2Laryngeal Neoplasms (Laryngeal Cancer)
12/2015 - 08/2010
2Starvation
09/2014 - 05/2007
2Pheochromocytoma
09/2012 - 07/2011
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2012 - 01/2012
1Obesity
01/2022
1Weight Loss (Weight Reduction)
01/2022
1Movement Disorders (Movement Disorder)
10/2021

Drug/Important Bio-Agent (IBA)

43Silybin (Lagosa)IBA
08/2022 - 09/2006
31oridoninIBA
12/2015 - 06/2004
16Reactive Oxygen Species (Oxygen Radicals)IBA
06/2013 - 10/2007
14CaspasesIBA
01/2020 - 09/2003
12evodiamineIBA
07/2010 - 01/2003
11Proteins (Proteins, Gene)FDA Link
04/2022 - 12/2006
10DiterpenesIBA
10/2017 - 06/2004
9pseudolaric acid BIBA
10/2017 - 12/2004
8Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2014 - 01/2008
5Biological ProductsIBA
01/2018 - 02/2004
5FlavonoidsIBA
10/2017 - 07/2004
5SilymarinIBA
11/2012 - 07/2004
5Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2012 - 02/2007
4Small Interfering RNA (siRNA)IBA
01/2022 - 01/2019
4Collagen Type I (Type I Collagen)IBA
01/2022 - 02/2015
4Amyloid (Amyloid Fibrils)IBA
01/2020 - 07/2011
4CollagenIBA
11/2019 - 01/2018
4AcidsIBA
10/2017 - 07/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 12/2005
4ErbB Receptors (EGF Receptor)IBA
11/2012 - 02/2007
3Dynamins (Dynamin)IBA
04/2022 - 01/2019
3Insulin (Novolin)FDA Link
01/2022 - 06/2018
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2017
31- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
11/2021 - 09/2021
3DNA (Deoxyribonucleic Acid)IBA
01/2021 - 06/2003
3Phosphotransferases (Kinase)IBA
01/2020 - 04/2005
3GelatinIBA
11/2019 - 01/2016
3JNK Mitogen-Activated Protein KinasesIBA
09/2018 - 09/2008
3physalin AIBA
09/2014 - 05/2013
3benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA
11/2013 - 12/2005
3Cytochromes c (Cytochrome c)IBA
12/2012 - 04/2009
3norcantharidinIBA
01/2012 - 08/2004
3Insulin-Like PeptidesIBA
04/2010 - 07/2008
3Sirtuin 1IBA
03/2007 - 04/2005
2LipidsIBA
01/2022 - 08/2018
2InterferonsIBA
11/2021 - 01/2021
2Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA
11/2021 - 01/2021
2mitochondrial transcription factor AIBA
01/2020 - 01/2019
2PPAR gammaIBA
01/2020 - 01/2019
2Estrogen Receptor alphaIBA
10/2019 - 07/2015
2Pattern Recognition ReceptorsIBA
12/2018 - 01/2018
2Toll-Like Receptor 3IBA
12/2018 - 01/2018
2RNA (Ribonucleic Acid)IBA
12/2018 - 01/2018
2bis-benzimidazoleIBA
01/2016 - 10/2012
2Antineoplastic Agents (Antineoplastics)IBA
12/2015 - 04/2010
2Caspase 9IBA
12/2015 - 08/2004
2AntioxidantsIBA
11/2012 - 04/2010
2RTKI cpdIBA
11/2012 - 08/2010
2Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric
09/2012 - 07/2011
2Mitomycin (Mitomycin-C)FDA LinkGeneric
05/2011 - 10/2009
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2008 - 12/2005
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
09/2008 - 01/2004
2Sepharose (Agarose)IBA
12/2005 - 08/2005
2shikoninIBA
04/2005 - 02/2004
1Long-Acting Thyroid Stimulator (LATS)IBA
01/2022
1SynucleinsIBA
10/2021
1Matrix Metalloproteinases (MMPs)IBA
09/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1DNA receptor (receptor, DNA)IBA
01/2021
1cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1Verteporfin (Visudyne)FDA Link
01/2020
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2020
1Metformin (Glucophage)FDA LinkGeneric
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020

Therapy/Procedure

4Therapeutics
09/2021 - 05/2008
2Aftercare (After-Treatment)
04/2009 - 09/2008
1Traditional Medicine (Folk Remedies)
04/2022
1Oral Administration
09/2021